Skip to main content
. 2022 May 9;2022:8523747. doi: 10.1155/2022/8523747

Table 3.

Relationship between operative method and final VA.

Operative method Final VA, n (%) Total
EE NLP LP HM CF-20/200 20/200 or better
INA 3 (42.9) 3 (42.9) 0 (0) 0 (0) 1 (14.2) 0 (0) 7 (3.0)
PPV 8 (21.6) 0 (0) 4 (10.8) 8 (21.6) 14 (37.8) 3 (8.1) 37 (15.9)
PPV + INA 5 (44.4) 1 (5.6) 3 (16.7) 2 (11.1) 2 (11.1) 5 (27.8) 18 (7.8)
PPV + oil 40 (27.6) 12 (8.3) 19 (13.1) 24 (16.6) 39 (26.9) 11 (7.6) 145 (62.5)
PPV + gas 1 (7.7) 0 (0) 0 (0) 4 (30.8) 7 (53.8) 1 (7.7) 13 (5.6)
Enucleated 0 (0) 5 (100) 0 (0) 0 (0) 0 (0) 0 (0) 5 (2.2)
Inv 2 (28.6) 0 (0) 1 (14.2) 0 (0) 2 (28.6) 2 (28.6) 7 (3.0)
Total 59 (25.4) 21 (91) 27 (11.6) 38 (16.4) 65 (28.0) 22 (9.5) 232

∗INA: intravitreal antibiotic injection; PPV: pars plana vitrectomy; PPV + oil: pars plana vitrectomy combined with silicone oil filling; PPV + gas: pars plana vitrectomy combined with gas filling; Inv: intravenous injection; VA: visual acuity; EE: enucleated or eviscerated; NLP: no light perception; LP: light perception; HM: hand motions; CF: counting fingers.